isoidide dinitrate: RN given refers to cpd without isomeric designation
ID Source | ID |
---|---|
PubMed CID | 170113 |
MeSH ID | M0043255 |
Synonym |
---|
38777-20-7 |
iditol, 1,4:3,6-dianhydro-, dinitrate |
isoidide dinitrate |
dianhydro-l-iditol-2,5-dinitrate |
(3r,3ar,6r,6ar)-6-(nitrooxy)-hexahydrofuro[3,2-b]furan-3-yl nitrate |
108032-10-6 |
EN300-19768138 |
Excerpt | Reference | Relevance |
---|---|---|
"Our objective was to determine the pharmacokinetic properties of the D- and L-enantiomers of isoidide dinitrate (IIDN) in relation to their hemodynamic effects." | ( Pharmacokinetic-hemodynamic studies of the enantiomers of isoidide dinitrate in conscious rats. Baur, R; Bennett, BM; Hayward, LD; Kempenaar, JW, 1991) | 0.75 |
Excerpt | Reference | Relevance |
---|---|---|
" The oral bioavailability of both enantiomers was low (ca." | ( Pharmacokinetic-hemodynamic studies of the enantiomers of isoidide dinitrate in conscious rats. Baur, R; Bennett, BM; Hayward, LD; Kempenaar, JW, 1991) | 0.53 |
Excerpt | Relevance | Reference |
---|---|---|
" The pharmacological effect following dinitrate dosing was analyzed by a sigmoidal Emax model assuming a simple additive effect of dinitrate and mononitrate." | ( Stereoselective pharmacokinetics and pharmacodynamics of organic nitrates in rats. Hatanaka, T; Ihara, K; Katayama, K; Kodera, M; Koizumi, T, 2001) | 0.31 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.46) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |